Fulcrum Therapeutics (FULC) Receivables - Net (2020 - 2022)

Fulcrum Therapeutics (FULC) has reported Receivables - Net for 3 consecutive years, with $13000.0 the latest figure, recorded in Q3 2022.

• In Q3 2022, Receivables - Net changed N/A year-over-year to $13000.0; the TTM figure through Sep 2022 stood at $13000.0 (changed N/A YoY), while the FY2021 annual figure was $2.5 million, up 25.0% from the prior year.
• Receivables - Net declined to $13000.0 in Q3 2022 per FULC's latest filing, from $357000.0 in the prior quarter.
• Across five years, Receivables - Net topped out at $2.5 million in Q4 2021 and bottomed at $13000.0 in Q3 2022.
• Historically, Receivables - Net has averaged $1.2 million across 3 years, with a median of $1.2 million in 2020.
• On a YoY basis, Receivables - Net climbed as much as 25.0% in 2021 and fell as far as 25.0% in 2021.
• Fulcrum Therapeutics' Receivables - Net stood at $2.0 million in 2020, then climbed by 25.0% to $2.5 million in 2021, then slumped by 99.48% to $13000.0 in 2022.
• Business Quant data shows FULC's Receivables - Net at $13000.0 in Q3 2022, $357000.0 in Q2 2022, and $2.5 million in Q4 2021.